Table 4.
Results of the logistic regression analysis to assess the associations between perioperative changes in endothelial glycocalyx concentrations and the occurrence of early postoperative outcomes.
| Unadjusted OR (95% CI) |
p-Value | Adjusted OR * (95% CI) |
p-Value | |
|---|---|---|---|---|
| Syndecan-1 (ng/mL) | ||||
| T0 | 1.02 (0.99–1.05) | 0.128 | 1.02 (0.99–1.05) | 0.139 |
| T1 | 1.02 (1.00–1.04) | 0.102 | 1.02 (1.00–1.04) | 0.093 |
| T2 | 1.03 (1.00–1.06) | 0.024 | 1.03 (1.00–1.06) | 0.023 |
| T0-T1 difference | 1.03 (0.99–1.08) | 0.147 | 1.04 (0.99–1.09) | 0.123 |
| T0-T2 difference | 1.08 (1.02–1.14) | 0.006 | 1.08 (1.03–1.15) | 0.005 |
| Heparan sulfate (ng/mL) | ||||
| T0 | 1.09 (0.97–1.21) | 0.154 | 1.10 (0.98–1.23) | 0.114 |
| T1 | 1.08 (0.95–1.22) | 0.255 | 1.09 (0.96–1.24) | 0.205 |
| T2 | 1.10 (0.97–1.25) | 0.157 | 1.11 (0.97–1.27) | 0.120 |
| T0-T1 difference | 0.65 (0.40–1.10) | 0.111 | 0.62 (0.36–1.07) | 0.088 |
| T0-T2 difference | 0.94 (0.65–1.34) | 0.715 | 0.93 (0.64–1.35) | 0.696 |
* Adjusted by age and sex. OR, odds ratio; CI, confidence interval; T0, preoperative baseline; T1, end of surgery; T2, 2 h post-surgery.